Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 

4-Traders Homepage  >  Equities  >  Nyse  >  CVS Health Corp    CVS

Delayed Quote. Delayed  - 08/25 10:02:41 pm
93.78 USD   -3.49%
08/24 CVS HEALTH : and Easterseals Celebrate Ten Years of Partnership to S..
08/23 CVS HEALTH : Research Institute Study Shows Value in Tailoring Medic..
08/23 Report says Citizens' R.I. tax credits skyrocket from $3.4M to $1..
SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsSector news 

Court Rules Two CVS Florida Pharmacies Can't Ship Pain Pills

share with twitter share with LinkedIn share with facebook
share via e-mail
0
03/22/2012 | 11:59pm CEST
   By John Kell 
   Of  
 

A U.S. appeals court said two CVS Caremark Corp. (>> CVS Caremark Corporation) pharmacies in Florida cannot fill prescriptions for certain controlled drugs related to a Drug Enforcement Administration move to halt such sales.

The decision lifted a temporary, administrative stay that was granted to CVS earlier this month, at the time allowing the pharmacies to keep dispensing controlled medications after an appeals court denied the chain's request for preliminary injunction.

The case stems from DEA action that was taken last month against two Sanford, Fla., CVS stores that were alleged to be among four pharmacy customers of drug distributor Cardinal Health Inc. (CAH) that dispensed the pain drug oxycodone based on bad prescriptions.

The U.S. Court of Appeals for the District of Columbia Circuit on Thursday ruled CVS had "not satisfied the stringent requirements for a stay pending appeal." The decision comes roughly a week after an appeals court said a Cardinal Health distribution hub in Florida can't ship prescription painkillers.

In a prepared statement, CVS said it was "disappointed with today's ruling by the court," saying the company had taken actions that have substantially reduced the amount of oxycodone dispensed at the two Florida pharmacies.

"We remain committed to working with the DEA to do everything we can to reduce prescription drug abuse," CVS said.

-By John Kell, Dow Jones Newswires; 212-416-2480; john.kell@dowjones.com

-Jon Kamp and Timothy Martin of The Wall Street Journal contributed to this article

Stocks mentioned in the article : CVS Caremark Corporation
share with twitter share with LinkedIn share with facebook
share via e-mail
0
Latest news on CVS HEALTH CORP
08/25 CVS HEALTH : Survey Reveals Two in Five Americans Make Multiple Trips to get Ent..
08/25 CVS HEALTH : and the CVS Health Foundation Announce $100K Donation In Support of..
08/24 CVS HEALTH : and Easterseals Celebrate Ten Years of Partnership to Support our N..
08/23 CVS HEALTH : Research Institute Study Shows Value in Tailoring Medication Adhere..
08/23 Report says Citizens' R.I. tax credits skyrocket from $3.4M to $11.9M in fisc..
08/22 CVS HEALTH : teams up with Roca to provide at-risk women with career training
08/18 CVS HEALTH : and the CVS Health Foundation Announce $100K Donation In Support of..
08/18 CVS HEALTH : Lipinski Announces Installation of Drop Box for Unwanted Prescripti..
08/18 CVS HEALTH : becomes latest Colorado pharmacy to offer opioid antidote without p..
08/17 CVS HEALTH : Makes Overdose-Reversal Drug Available Without A Prescription At Al..
More news
Sector news : Drug Retailers - NEC
08/22DJSINOPHARM GROUP : 1st Half Net Profit CNY2.53 Billion, Up 32% on Year
08/09DJPatient Survey Company Press Ganey to Sell Itself to Swedish Firm EQT
08/09DJValeant Posts a Loss and Says It Will Retool
08/02DJCARDINAL HEALTH : Warns of Quarterly Profit Decline
08/02DJCARDINAL HEALTH : Warns of Quarterly Profit Decline
More sector news : Drug Retailers - NEC
News from SeekingAlpha
08/25 Amazon v. Wal-Mart In Brewing Takeover Battle
08/22 Why I Didn't Buy Gilead, Apple Or 100 Others, Y'all - Part 3
08/21 MY PORTFOLIO UPDATE AND REVIEW OF 83 : Up 2 With Reynolds And Exelon, Down 1 Wit..
08/17 10 Dividend Growth Stocks For August 2016
08/16 SNIPPET ROUNDUP : Biogen Buy Rumours, CVS Cuts And Spark Gains On Shire's Loss
Advertisement
Financials ($)
Sales 2016 179 904 M
EBIT 2016 10 782 M
Net income 2016 5 700 M
Debt 2016 24 998 M
Yield 2016 1,74%
P/E ratio 2016 18,13
P/E ratio 2017 15,08
EV / Sales 2016 0,69x
EV / Sales 2017 0,64x
Capitalization 99 990 M
More Financials
Chart CVS HEALTH CORP
Duration : Period :
CVS Health Corp Technical Analysis Chart | CVS | US1266501006 | 4-Traders
Full-screen chart
Technical analysis trends CVS HEALTH CORP
Short TermMid-TermLong Term
TrendsNeutralBearishNeutral
Technical analysis
Income Statement Evolution
More Financials
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 25
Average target price 111 $
Spread / Average Target 19%
Consensus details
EPS Revisions
More Estimates Revisions
Managers
NameTitle
Larry J. Merlo President, CEO & Non-Independent Director
David Wyatt Dorman Non-Executive Chairman
David M. Denton Chief Financial Officer & Executive Vice President
Troyen A. Brennan Chief Medical Officer & Executive Vice President
Stephen J. Gold Chief Information Officer & Executive Vice Preside
More about the company
Sector and Competitors
1st jan.Capitalization (M$)
CVS HEALTH CORP-4.08%103 604
WALGREENS BOOTS ALLIAN..-5.84%88 176
EXPRESS SCRIPTS HOLDIN..-17.93%48 111
MCKESSON CORPORATION-7.06%42 669
CARDINAL HEALTH INC-11.10%25 831
AMERISOURCEBERGEN CORP..-17.55%18 980
More Results